These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20578180)
1. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Winget M; Hossain S; Yasui Y; Scarfe A Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180 [TBL] [Abstract][Full Text] [Related]
2. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Eldin NS; Yasui Y; Scarfe A; Winget M Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914 [TBL] [Abstract][Full Text] [Related]
3. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Lima IS; Yasui Y; Scarfe A; Winget M Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156 [TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928 [TBL] [Abstract][Full Text] [Related]
5. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591 [TBL] [Abstract][Full Text] [Related]
6. Referral rate to oncologists and its variation by hospital for colorectal cancer patients. Kreiter E; Yasui Y; de Gara C; White J; Winget M Ann Surg Oncol; 2012 Mar; 19(3):714-21. PubMed ID: 21922337 [TBL] [Abstract][Full Text] [Related]
7. Survival and time interval from surgery to start of chemotherapy among colon cancer patients. Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115 [TBL] [Abstract][Full Text] [Related]
9. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
10. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055 [TBL] [Abstract][Full Text] [Related]
11. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089 [TBL] [Abstract][Full Text] [Related]
15. Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada. Winget M; Fleming J; Li X; Gao Z; Butts C Lung Cancer; 2011 Apr; 72(1):52-8. PubMed ID: 20708293 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. Shankaran V; Jolly S; Blough D; Ramsey SD J Clin Oncol; 2012 May; 30(14):1608-14. PubMed ID: 22412136 [TBL] [Abstract][Full Text] [Related]
17. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer. Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558 [TBL] [Abstract][Full Text] [Related]
18. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana. Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095 [TBL] [Abstract][Full Text] [Related]
19. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]